[11] [12] En el estudio pivotal SURMOUNT-1, los participantes que recibieron la dosis mxima de tirzepatida (15 mg semanales) experimentaron una reduccin promedio del peso corporal del 20.9% a las 72 semanas, comparado con 3.1% en el grupo placebo
The most effective treatment varies by individual and should be determined by a healthcare provider
[DOI] [PubMed] 170.Pearl P.L., Gibson K.M., Cortez M., Wu Y., Carter Snead O., Knerr I., Forester K., Pettiford J., Jakobs C., Theodore W
The recipes use whole-food ingredients, and the images are beautiful and appetizing, inspiring you to actually want to cook and try something new. She adds that the instructions are easy to follow, with familiar ingredients that wont have you scratching your head
In the phase III liraglutide program (SCALE study) ~4000 participants with obesity were studied for up to three years [16]
These are all FDA-approved medications that have been extensively studied